DE FIRE VIGTIGSTE fordele ved at anvende IV3000 som bandage ved iv-indstikssteder
Infektionsrisiko:
IV3000 reducerer infektionsrisikoen ved at:
- Minimere potentialet for bakterievækst, da den forhindrer akkumulering af fugt, takket være IV3000 filmen, der muliggør optimal overførsel af fugtdampning1-4;
- Fungere som en barriere over for bakterier5,6;
- Fungere som virusbarriere7;
- Reducere forekomsten af enhedsrelateret sepsis3.
Patientkomfort
IV3000 giver større patientkomfort8, da den:
- Mindsker smerter ved fjernelse9;
- Er vandtæt, så patienten kan tage brusebad med bandagen in situ.10-12.
Hudintegritet
IV3000 bevarer hudintegriteten gennem andre produktegenskaber.
- Klæber med lav risiko for allergi3,4,9,13;
- Hjælper med at forebygge maceration1-2,11,
- Irriterer ikke huden13;
- Ikke-sensibiliserende 13.
Klinisk praksis
IV3000 understøtter god klinisk praksis ved at:
- Give fremragende kateteterstabilitet, og nem fjernelse3,9,14-15;
- Muliggøre nem aseptisk fiksering og nem fjernelse9;
- Reducere antallet af ikke-planlagte bandageskift.16;
- Bandagen kan bæres i op til 7 dage10,17-18;
- Muliggøre løbende inspektion af kateterindstiksstedet
Referencer
1 M. Richardson, An in vivo assessment of the microbial proliferation beneath transparent film dressing, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Symposium Series No.179. Royal Society of Medicine Services Limited, 1991, pp. 29-33.
2 B. Joyeux, OPSITE™ IV3000 versus Tegaderm™ on peripheral venous catheters, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Symposium Series No.179. Royal Society of Medicine Services Limited, 1991, pp. 53-55.
3 D. G. M. Maki, S. S. M. Stolz, S. B. Wheeler and L. A. D. S. Memel, "A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management," Critcial Care Medicine, vol. 22, no. 11, pp. 1729-1737, 1994.
4 D. G. Maki, "Preliminary Analysis of Data from the Triple-Lumen Central Venous Catheter Study," 1992.
5 Smith & Nephew, "Data On File Report 0505005. In-vitro," 2005.
6 Smith & Nephew, "Bacteria barrier testing of IV3000 Report WRP-TW042-281," 2003.
7 Smith & Nephew, Bacterial Viral Barrier Claim For IV3000 Transparent Dressing Family. Statement Reference 200409902-01, 2004.
8 S. Wheeler, S. Stolz and D. Maki, "A prospective, randomized, three-way clinical comparison of a novel, highly permeable, polyurethane dressing with 206 Swan-Ganz pulmonary artery catheters: OPSITE IV3000 vs Tegaderm vs gauze and tape," pp. 67-72, 1991.
9 J. Willie, B. Van Oud Alblas and E. Thewessen, "A comparison of two transparent film-type dressing in central vanous therapy," Journal of Hospital Infection, vol. 23, pp. 113-121, 1993.
10 M. Besley, OPSITE IV3000: potential for improved quality of life for haemodialysis patients with permanent central venous catheters, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Synposium Series No. 179. Royal Society of Medicine Services Limited, 1991, pp. 57-59.
11 L. Tompkins, "Data on File Report DS/07/224/R1a. IV3000 I-Hand Physical Properties.," 2008.
12 "Preventing Hospital- Acquired Infection- Clinical Guidelines Public Health Laboratory Service," 1997.
13 G. Walton, "Safety Statement," 2011.
14 A. Wallace and B. Davy, "Report Ref. L/75A/23. To evaluate the skin response to, and tape performance of, single and repeat applications of high MVP dressings in human volunteers.," 1985.
15 D. Maki and M. Ringer, "Evalutation of Dressing Regimens for Prevention of Infection With Peripheral Intravenous Catheters," JAMA, vol. 258, no. 17, pp. 2395-2403, 6 Nov 1987.
16 M. Neufeld, A Randomized Control Trial of the effectiveness of Opsite Wound versus IV3000 in maintaining and Occlusive Central Line Dressing, McMaster University Canada, 1991.
17 D. R. R. Keenlyside, "Avoiding an unnecessary outcome. A comparative trial between IV3000 and a conventional film dressing to assess rates of catheter-related sepsis," Professional Nurse, pp. 288-291, February 1993.
18 C. Latta and C. Grant, "IV3000 dressing on Permcath exit sites," 1996.
Alle varemærker tilhører de respektive ejere.
Informationen på den viste dokumentationslabel på bannerbilledet gives kun i markedsføringsøjemed..